Valuation: Balchem Corporation

Market Cap 5.34B 4.64B 4.32B 3.97B 7.49B 510B 7.61B 50.94B 19.99B 254B 20.06B 19.62B 851B P/E 2026 *
32.2x
P/E 2027 * 31.2x
Enterprise Value 5.33B 4.63B 4.31B 3.96B 7.48B 509B 7.59B 50.83B 19.95B 253B 20.02B 19.58B 849B EV / Sales 2026 *
4.81x
EV / Sales 2027 * 4.45x
Free-Float
99.53%
Yield 2026 *
0.67%
Yield 2027 * 0.76%
1 day+2.97%
1 week+2.91%
1 month-0.79%
3 months+3.74%
6 months-1.54%
Current year+9.26%
1 week 160.46
Extreme 160.455
169.57
1 month 159.34
Extreme 159.34
169.57
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 62.92
Extreme 62.92
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 56 2025-09-30
Director TitleAgeSince
Director/Board Member 63 2010-09-15
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Date Insider Type Main position Quantity % Market Cap.
2/11/26 Free

Director

870 0.0027%
2/11/26 Free

Director

870 0.0027%
2/11/26 Free

General Counsel

11,315 0.0349%
Change 5-day change 1-year change 3-year change Capi.($)
+2.97%+2.91%+10.11%+25.79% 5.34B
-0.61%+3.30%+6.37%+49.93% 78.14B
-1.73%+1.06%-5.31%+9.90% 36.85B
+1.11%+16.68%-5.58%-32.82% 36.06B
-1.54%+4.03%+19.37%+36.34% 28.07B
-0.30%+3.61%+27.24%+12.60% 23.63B
-2.00%-2.43%+87.32%-6.95% 19.15B
-1.33%-0.51%-34.71%-40.72% 18.5B
-3.00%+2.53%+13.91%-8.62% 14.02B
-0.10%+2.43%+73.25%-43.44% 13.87B
Average -0.65%+3.36%+19.20%+0.20% 27.36B
Weighted average by Cap. -0.78%+4.11%+13.10%+10.70%

Financials

2026 *2027 *
Net sales 1.11B 963M 897M 823M 1.55B 106B 1.58B 10.57B 4.15B 52.67B 4.16B 4.07B 177B 1.17B 1.01B 944M 867M 1.64B 111B 1.66B 11.13B 4.37B 55.46B 4.38B 4.29B 186B
Net income 168M 146M 136M 125M 236M 16.06B 240M 1.6B 630M 7.99B 632M 618M 26.8B 174M 151M 141M 129M 244M 16.59B 248M 1.66B 651M 8.26B 653M 638M 27.69B
Net Debt -11.86M -10.31M -9.6M -8.81M -16.64M -1.13B -16.9M -113M -44.4M -564M -44.55M -43.57M -1.89B -153M -133M -124M -114M -215M -14.63B -218M -1.46B -574M -7.28B -576M -563M -24.43B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,352
Date Price Change Volume
26-07-31 US$167.56 +2.97% 346,156
26-07-30 US$162.73 -0.60% 271,851
26-07-29 US$163.71 -1.25% 157,702
26-07-28 US$165.79 +0.61% 317,890
26-07-27 US$164.79 +1.22% 138,914
Trader
Investor
Global
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
167.56USD
Average target price
200.75USD
Spread / Average Target
+19.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock